Figure 1From: In non-transplant patients with multiple myeloma, the pre-treatment level of clonotypic cells predicts event-free survivalSensitivity of patient-specific RPCR. The bars represent the mean of 3 replicate PCR reactions to determine the VDJ% for each dilution noted by comparing the VDJ PCR molecule count plotted from the VDJ control curve to the β2m molecule count using half the DNA. The absence of bars at the 0.0001%, 0.00001% and 0.000001% levels indicate the absence of amplification.Back to article page